These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1722348)

  • 61. Monitoring antibody titers to recombinant Core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy.
    Park YM; Byun BH; Choi JY; Bae SH; Kim BS; So HS; Ryu WS
    J Korean Med Sci; 1999 Apr; 14(2):165-70. PubMed ID: 10331562
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Detection of hepatitis C viral sequences in non-A, non-B hepatitis.
    Weiner AJ; Kuo G; Bradley DW; Bonino F; Saracco G; Lee C; Rosenblatt J; Choo QL; Houghton M
    Lancet; 1990 Jan; 335(8680):1-3. PubMed ID: 1967327
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Enzyme-linked immunosorbent assay for antibodies against core protein of hepatitis C virus with a synthetic oligopeptide].
    Sugiyasu T
    Fukuoka Igaku Zasshi; 1993 Apr; 84(4):148-58. PubMed ID: 7686127
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Serodiagnostic assay of hepatitis C virus infection using viral proteins expressed in Escherichia coli.
    Mori S; Ohkoshi S; Hijikata M; Kato N; Shimotohno K
    Jpn J Cancer Res; 1992 Mar; 83(3):264-8. PubMed ID: 1316340
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prevalence of hepatitis C virus infections in dialysis patients and their contacts using a second generation enzymed-linked immunosorbent assay.
    Schlipköter U; Gladziwa U; Cholmakov K; Weise A; Rasshofer R; Lorbeer B; Luz N; Deinhardt F; Roggendorf M
    Med Microbiol Immunol; 1992; 181(3):173-80. PubMed ID: 1381808
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Human antibodies to dengue and yellow fever do not react in diagnostic assays for hepatitis C virus.
    Yoshida CF; Rouzerè CD; Nogueira RM; Lampe E; Travassos-da-Rosa MA; Vanderborght BO; Schatzmayr HG
    Braz J Med Biol Res; 1992; 25(11):1131-5. PubMed ID: 1285268
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hepatitis C virus (HCV) viremia in human immunodeficiency virus-seronegative and -seropositive patients with indeterminate HCV recombinant immunoblot assay.
    Marcellin P; Martinot-Peignoux M; Elias A; Branger M; Courtois F; Level R; Erlinger S; Benhamou JP
    J Infect Dis; 1994 Aug; 170(2):433-5. PubMed ID: 7518489
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Antibodies against hepatitis C virus. Experience with a second generation test].
    Garassini MA; Ortega F; Alvarado M; Valdés A; Díaz F; Dugarte I; Serrano L
    G E N; 1991; 45(3):183-9. PubMed ID: 1726913
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Significance of anti-E2 in the diagnosis of HCV infection in patients on maintenance hemodialysis: anti-E2 is frequently detected among anti-HCV antibody-negative patients.
    Lee DS; Lesniewski RR; Sung YC; Min WK; Park SG; Lee KH; Kim HS
    J Am Soc Nephrol; 1996 Nov; 7(11):2409-13. PubMed ID: 8959633
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Should the c100 antigen be removed from HCV antibody assays?
    Zaaijer HL; Cuypers HT; Reesink HW; Lelie PN
    Vox Sang; 1994; 66(2):150. PubMed ID: 7514326
    [No Abstract]   [Full Text] [Related]  

  • 71. Significance of IgM antibody to hepatitis C virus in patients with chronic hepatitis C.
    Brillanti S; Masci C; Ricci P; Miglioli M; Barbara L
    Hepatology; 1992 Jun; 15(6):998-1001. PubMed ID: 1317344
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
    Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
    Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-alpha 2b.
    Saracco G; Rosina F; Abate ML; Chiandussi L; Gallo V; Cerutti E; Di Napoli A; Solinas A; Deplano A; Tocco A
    Hepatology; 1993 Dec; 18(6):1300-5. PubMed ID: 7694894
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immune response to GOR, a marker for non-A, non-B hepatitis and its correlation with hepatitis C virus infection.
    Mehta SU; Mishiro S; Sekiguchi K; Leung T; Dawson GJ; Pendy LM; Peterson DA; Devare SG
    J Clin Immunol; 1992 May; 12(3):178-84. PubMed ID: 1383257
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical significance of the antibody to the putative core protein of hepatitis C virus in patients with chronic liver disease.
    Manzini P; Calvo PL; Brunetto MR; Baldi M; Abate ML; Oliveri F; Negro F; Balzola F; Saracco G; Verme G
    Liver; 1993 Aug; 13(4):222-6. PubMed ID: 7690874
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Diagnostic possibilities of an immunoenzyme test-system for determining the spectrum of antibodies to structural and nonstructural hepatitis C virus antigens].
    Pimenov VK; Afanas'ev AIu; Kolobov AA; Zubov SV; Dobrotina NA; Novikov VV
    Vopr Virusol; 2000; 45(6):44-7. PubMed ID: 11200648
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Clinical significance of antibody to Y19 protein in nonA and nonB chronic liver disease].
    Sakashita H
    Fukuoka Igaku Zasshi; 1993 Apr; 84(4):159-72. PubMed ID: 7686128
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Anti-HCV immunoglobulin M antibody in patients with acute and fulminant hepatitis C.
    Akbar SM; Onji M; Horiike N; Ohta Y
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():71-5. PubMed ID: 7689511
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Detection of antibodies to hepatitis C virus (HCV) structural proteins in anti-HCV-positive sera by an enzyme-linked immunosorbent assay using synthetic peptides as antigens.
    Ishida C; Matsumoto K; Fukada K; Matsushita K; Shiraki H; Maeda Y
    J Clin Microbiol; 1993 Apr; 31(4):936-40. PubMed ID: 7681849
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of commercially available third-generation anti-hepatitis C virus enzyme-linked immunosorbent assay in patients on haemodialysis.
    Lakshmi V; Reddy AK; Dakshinamurty KV
    Indian J Med Microbiol; 2007 Apr; 25(2):140-2. PubMed ID: 17582185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.